Insider Trading activities of Biomarin Pharmaceutical Inc insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biomarin Pharmaceutical Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Biomarin Pharmaceutical Inc since 2005. The reporting company's ticker symbol is BMRN. The reporting company's CIK number is 1048477.
The total value of stock buying since 2005 is $1,114,124.
The total value of stock sales since 2005 is $424,118,306.
The total value of stock option exercises since 2005 is $120,949,502.



Table 2. Detailed insider stock purchases, sales, and option exercises of Biomarin Pharmaceutical Inc insiders (BMRN) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-03-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 12.99 38,970
2015-01-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 94.14 188,286
2014-12-24 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 88.73 443,655
2014-12-24 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 12.99 38,970
2014-12-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 95.00 190,000
2014-12-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2014-12-04 Lewis Alan Sale 7,500 89.90 674,227
2014-12-04 Lewis Alan Option Ex 7,500 21.51 161,325
2014-12-03 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 12,000 91.01 1,092,156
2014-12-03 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 12,000 38.59 463,080
2014-12-02 Mueller Brian (VP, Corporate Controller) Sale 5,000 91.82 459,099
2014-12-02 Mueller Brian (VP, Corporate Controller) Option Ex 5,000 28.23 141,150
2014-12-01 Mueller Brian (VP, Corporate Controller) Sale 6,950 90.25 627,237
2014-12-01 Mueller Brian (VP, Corporate Controller) Option Ex 6,950 17.95 124,752
2014-11-26 Mueller Brian (VP, Corporate Controller) Sale 3,400 88.97 302,508
2014-11-25 Davis George Eric (SVP, General Counsel) Sale 20,000 89.75 1,795,000
2014-11-25 Davis George Eric (SVP, General Counsel) Option Ex 20,000 26.49 529,800
2014-11-25 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 90.00 180,000
2014-11-25 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2014-11-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 81.51 81,513
2014-11-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 87.00 348,000
2014-11-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 12.99 51,960
2014-11-10 Fuchs Henry J (EVP, Chief Medical Officer) Sale 20,000 86.55 1,730,980
2014-11-10 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 20,000 21.51 430,200
2014-11-03 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 47 83.54 3,926
2014-11-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 85.33 256,002
2014-10-30 Davis George Eric (SVP, General Counsel) Sale 15,000 83.19 1,247,925
2014-10-30 Davis George Eric (SVP, General Counsel) Option Ex 15,000 26.49 397,350
2014-10-30 Baffi Robert (EVP, Technical Operations) Sale 29,963 81.70 2,447,947
2014-10-30 Baffi Robert (EVP, Technical Operations) Option Ex 29,963 38.59 1,156,272
2014-10-29 Baffi Robert (EVP, Technical Operations) Sale 45,462 81.10 3,686,968
2014-10-29 Baffi Robert (EVP, Technical Operations) Option Ex 45,462 24.49 1,113,227
2014-10-24 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 80.00 160,000
2014-10-24 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2014-10-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 75.00 150,000
2014-10-21 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2014-09-19 Davis George Eric (SVP, General Counsel) Sale 17,536 69.75 1,223,136
2014-09-19 Davis George Eric (SVP, General Counsel) Option Ex 17,536 21.51 377,199
2014-09-03 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 18 69.77 1,255
2014-09-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 16,000 69.83 1,117,312
2014-09-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 16,000 39.06 624,960
2014-08-20 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 70.00 350,000
2014-08-20 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2014-08-05 Fuchs Henry J (EVP, Chief Medical Officer) Sale 10,000 65.00 650,000
2014-08-05 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 21.51 215,100
2014-08-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 2,229 61.76 137,651
2014-07-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 2,229 64.00 142,656
2014-06-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 62.52 62,521
2014-06-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 59.88 59,876
2014-06-02 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 377 57.84 21,803
2014-05-22 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 56.88 56,876
2014-05-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,545 56.19 86,816
2014-05-16 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 1,004 56.91 57,135
2014-05-16 Lawlis V Bryan Sale 1,700 56.87 96,672
2014-05-16 Fuchs Henry J (EVP, Chief Medical Officer) Sale 1,864 56.86 105,994
2014-05-13 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 478 58.18 27,809
2014-05-13 Fuchs Henry J (EVP, Chief Medical Officer) Sale 1,434 58.23 83,497
2014-05-09 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 621 57.96 35,991
2014-05-09 Fuchs Henry J (EVP, Chief Medical Officer) Sale 3,479 57.91 201,475
2014-05-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 11 58.40 642
2014-05-01 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 666 59.55 39,660
2014-05-01 Fuchs Henry J (EVP, Chief Medical Officer) Sale 715 59.67 42,666
2014-03-28 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2014-03-06 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 17,370 78.63 1,365,837
2014-03-06 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 17,370 24.87 431,991
2014-03-05 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 12 82.93 995
2014-03-03 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 8,000 80.32 642,528
2014-03-03 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 8,000 39.06 312,480
2014-02-20 Davis George Eric (SVP, General Counsel) Sale 20,000 80.00 1,600,000
2014-02-20 Davis George Eric (SVP, General Counsel) Option Ex 20,000 21.51 430,200
2014-02-20 Bienaime Jean Jacques (Chief Executive Officer) Sale 8,000 80.00 640,000
2014-02-06 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 12.99 51,960
2014-02-03 Fuchs Henry J (EVP, Chief Medical Officer) Sale 10,000 67.70 676,970
2014-02-03 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 21.51 215,100
2014-01-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 70.00 350,000
2014-01-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2014-01-06 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 67.41 674,100
2014-01-06 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 12.99 129,900
2014-01-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 68.90 344,485
2014-01-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2014-01-02 Fuchs Henry J (EVP, Chief Medical Officer) Sale 916 68.97 63,171
2013-12-24 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 68.71 687,140
2013-12-11 Grey Michael G Sale 30,000 69.66 2,089,680
2013-12-11 Grey Michael G Option Ex 30,000 21.78 653,310
2013-12-09 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 13,026 69.55 906,010
2013-12-09 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 13,026 17.92 233,425
2013-12-09 Lawlis V Bryan Sale 2,900 69.76 202,301
2013-12-09 Lewis Alan Sale 22,500 69.91 1,572,975
2013-12-09 Lewis Alan Option Ex 22,500 32.54 732,150
2013-12-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 69.70 348,485
2013-12-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 9,000 70.14 631,269
2013-12-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 9,000 39.06 351,540
2013-11-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2013-11-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 62.36 311,780
2013-11-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2013-11-01 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 99 63.16 6,252
2013-10-31 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 62.72 627,160
2013-10-31 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 12.99 129,900
2013-10-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 67.72 135,450
2013-10-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2013-10-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 66.76 200,292
2013-09-19 Fuchs Henry J (EVP, Chief Medical Officer) Sale 10,000 80.19 801,900
2013-09-19 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 11.05 110,500
2013-09-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 73.08 146,164
2013-09-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2013-09-09 Baffi Robert (EVP, Technical Operations) Sale 20,000 73.00 1,460,000
2013-09-09 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 21.51 430,200
2013-09-05 Fuchs Henry J (EVP, Chief Medical Officer) Sale 10,000 70.00 700,000
2013-09-05 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 11.05 110,500
2013-09-04 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 9,000 69.00 621,000
2013-09-04 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 9,000 39.06 351,540
2013-08-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 64.36 64,364
2013-08-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 12.99 12,990
2013-07-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 38.34 76,688
2013-07-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 4,066 59.78 243,061
2013-07-01 Fuchs Henry J (EVP, Chief Medical Officer) Sale 10,000 60.00 600,000
2013-07-01 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 11.05 110,500
2013-06-12 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2013-06-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 20,000 43.89 877,800
2013-06-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 20,000 36.85 737,099
2013-06-03 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 493 58.34 28,763
2013-06-03 Fuchs Henry J (EVP, Chief Medical Officer) Sale 1,098 58.32 64,036
2013-05-31 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 12.99 38,970
2013-05-23 Fuchs Henry J (EVP, Chief Medical Officer) Sale 8,710 67.16 584,981
2013-05-22 Wood Mark (VP, Human Resources) Sale 3,103 67.12 208,282
2013-05-22 Wood Mark (VP, Human Resources) Option Ex 3,103 24.96 77,457
2013-05-22 Fuchs Henry J (EVP, Chief Medical Officer) Sale 11,899 65.66 781,240
2013-05-22 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 11.05 110,500
2013-05-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 64.14 128,277
2013-05-21 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2013-05-17 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 64.01 320,050
2013-05-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 64.65 129,306
2013-05-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 7,000 38.82 271,754
2013-05-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 68.55 685,480
2013-05-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 12.99 129,900
2013-05-14 Mueller Brian (VP, Corporate Controller) Sale 4,947 70.37 348,130
2013-05-14 Mueller Brian (VP, Corporate Controller) Option Ex 3,500 21.51 75,285
2013-05-14 Davis George Eric (SVP, General Counsel) Sale 20,000 70.34 1,406,800
2013-05-14 Davis George Eric (SVP, General Counsel) Option Ex 20,000 21.51 430,200
2013-05-14 Baffi Robert (EVP, Technical Operations) Sale 20,000 70.00 1,400,000
2013-05-14 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 21.51 430,200
2013-05-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 40,000 70.56 2,826,590
2013-05-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 40,000 12.99 519,600
2013-05-13 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 1,248 69.25 86,430
2013-05-13 Davis George Eric (SVP, General Counsel) Sale 2,590 69.29 179,453
2013-05-13 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 68.98 1,034,640
2013-05-13 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 8,000 12.99 103,920
2013-05-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 800 67.48 53,984
2013-05-09 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 811 66.00 53,528
2013-05-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 65.88 65,879

Insider trading activities including stock purchases, stock sales, and option exercises of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN, CIK number 1048477) see the Securities and Exchange Commission (SEC) website.